Aktien.Guide
NASDAQ Growth Stars
5 Hits · last calculated November 2, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 5 hits from US
Methodology & criteria
Growth stars from the NASDAQ-100: index member, revenue growth (trailing 12 months) above 20%, and EV/Sales ratio below 10 — fast growth that isn't yet priced astronomically. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MU Micron Technology Inc | — | +511 % | 81 % | Stage 2 | A 89 | 6 of 9 | 1,149.3 $ | Semiconductors | Sells AI | — | Technology | 884.70 $ | +268.7 % | +299.8 % | +295.4 % | −3.3 % | +76.5 % | 99 | 96 | 10.6 % | 9.5 % | 2.23 | 18.4 | 5.1 | 8.6 | 9.1 | 16.2 | 0.16 | 8.8 | 80.4 % | 80.7 % | 63.8 % | 39.8 % | 44.6 % | 0.06 | 75.1 % | +48.9 % | 9 | 0.1 % | 0.8 % | 11.7 | 81.6 % | 2.0 % | 4.6 (49) | |
| FANG Diamondback Energy Inc | 08/03 | +22 % | 33 % | Stage 2 | C 51 | 6 of 9 | 59.6 $ | Oil & Gas E&P | – | — | — | Energy | 212.10 $ | +26.4 % | +24.3 % | +52.8 % | −14.9 % | +15.0 % | 61 | 2 | 2.5 % | 3.2 % | 0.54 | 216.3 | 11.7 | 3.5 | 1.6 | 8.0 | 22.29 | 5.8 | 5.8 % | 72.4 % | 9.0 % | 0.5 % | 1.3 % | 0.38 | 52.0 % | +36.3 % | 5 | 2.1 % | 27.4 % | 4.7 | 70.2 % | 3.8 % | 4.5 (32) |
| META Meta Platforms Inc. | 07/29 | +32 % | 41 % | Stage 4 | B 69 | 5 of 9 | 1,565.7 $ | Internet Content & Information | Sells AI | — | Communication Services | 615.00 $ | -14.7 % | -15.6 % | -7.4 % | −31.8 % | +37.9 % | 19 | 80 | 3.4 % | 3.1 % | 1.19 | 22.8 | 18.2 | 6.5 | 6.5 | 54.7 | 0.82 | 15.3 | 40.6 % | 81.0 % | 31.2 % | 32.9 % | 14.6 % | 0.40 | 61.7 % | +22.2 % | 9 | 0.3 % | 7.0 % | 8.8 | 79.3 % | 1.3 % | 4.6 (62) | |
| DASH DoorDash, Inc. | 08/05 | +45 % | 50 % | Stage 4 | B 65 | 3 of 9 | 78.3 $ | Internet Retail | – | — | — | Consumer Cyclical | 179.00 $ | -24.3 % | -20.4 % | -29.6 % | −38.0 % | +40.9 % | 19 | 28 | 5.7 % | 5.2 % | 1.89 | 87.3 | 29.4 | 4.6 | 8.2 | 31.8 | 0.81 | 35.8 | 5.3 % | 52.7 % | 6.2 % | 9.9 % | 3.6 % | 0.70 | 51.7 % | +27.9 % | 7 | 0.0 % | 0.0 % | 4.8 | 97.1 % | 4.1 % | 4.4 (43) |
| ALNY Alnylam Pharmaceuticals Inc | 07/30 | +17 % | 59 % | Stage 4 | A 81 | 7 of 9 | 21.9 $ | Biotechnology | Uses AI | — | Healthcare | 165.00 $ | -27.5 % | -26.7 % | -63.3 % | −40.8 % | +62.2 % | 17 | 42 | 3.4 % | 3.4 % | 0.27 | 42.6 | 17.5 | 4.4 | 21.1 | — | 0.29 | 25.3 | 23.0 % | 79.7 % | 16.1 % | 90.4 % | 12.3 % | 1.18 | 21.0 % | +65.2 % | 8 | 0.0 % | 0.0 % | 4.2 | 102.1 % | 7.7 % | 4.3 (30) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Growth stars from the NASDAQ-100: index member, revenue growth (trailing 12 months) above 20%, and EV/Sales ratio below 10 — fast growth that isn't yet priced astronomically. Source: fundamental data.
All scanners are recalculated daily across the entire stock universe — most recently on November 2, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 5 stocks pass this scanner's criteria (as of November 2, 2026).
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.